I really don't want to be a doctor

Chapter 478 Shut down? !
Of course, the volume of the entire Golden View Catering must be more than 1000 million, but the company's liquidity must not be much, not to mention that it is still in the development stage of Golden King Catering.

Jin Miao was able to take out 1000 million, which already surprised Jing Xiaoran.

In the following time, Jing Xiaoran and Weng Huijin started to deal with the affairs of the pharmaceutical factory.

All the equipment and production lines of the pharmaceutical factory depend on Li's Pharmaceutical Factory.

As Li Feng's spokesperson in Fancheng, Li Feng is in charge of the cooperation with Shenzhou Laboratory.

"Did you find the location of the pharmaceutical factory so quickly?" Li Feng was drinking with a group of friends in the bar, and he was very surprised when he heard the news from Jing Xiaoran on the phone.

When he heard that Jing Xiaoran wanted to start a pharmaceutical factory independently, he knew it would not be an easy task.

"Well, in the eastern suburbs of Fancheng, do you have time to visit together?" Jing Xiaoran said.

"Okay, give me your address, and I'll pick you up right away." Li Feng said immediately.

Although he likes to have fun, he also knows that the cooperation with Shenzhou Lab is of great importance.

"Brothers, I still have feelings, let's go first, and make an appointment next time." Li Feng said goodbye to his new friends in Fancheng.

This small group is not headed by Li Feng, so everyone naturally dare not have any objections.

……

Soon, Jing Xiaoran met Li Feng.

This time, Jin Miao also arrived.

As a person in the business circle, Li Feng has long been familiar with the name Jinjing Catering.

Although Jin Miao is not in the pharmaceutical industry, he is very aware of the influence of Li's Pharmaceutical Factory in China.

When the two met for the first time, it was naturally a scene of "asking for warmth".

Seeing the scene where the two had a happy conversation, Jing Xiaoran suddenly felt that the two "smelled like each other".

"The conditions here are good. Although the work is relatively old, it should be enough as a pharmaceutical factory. And with a little decoration, it should be able to have very good results." Li Feng said.

"The largest concentration of factories in the eastern suburbs of Fancheng is here." Jin Miao nodded, "There are many different factories here. Although some factories are old, it is very convenient to move nearby equipment."

"Brother Jin is right, he has a good eye!" Li Feng gave a thumbs up.

"Brother Li, you are too much." Jin Miao smiled.

"If you have time, let's have dinner together in the evening?" Li Feng suddenly approached Jin Miao and invited him.

"Okay, I'm the host in Fancheng, I'm here to treat you." Jin Miao said, then turned to look at Jing Xiaoran, "Xiao Ran, are you coming?"

Jing Xiaoran looked at the two speechlessly, "Forget it, you two go eat, I still have to deal with the time of the pharmaceutical factory."

Seeing Jing Xiaoran's refusal, Jin Miao and Li Feng didn't force it, and the two continued to chat about various business circles.

Jing Xiaoran, a shareholder of "Golden King Catering" who is not worthy of the name, can't get in the way at all.

However, after this on-the-spot investigation, he and Li Feng were very satisfied with the address of the pharmaceutical factory, and the only thing left to do was to renovate the factory.

……

Days go by.

The clinical trial of "immune checkpoint inhibitors" in Shenzhou Laboratory has been carried out for two months.

At present, the international scientific research situation is divided into two poles, one is AstraZeneca under the spotlight of the media, and the other is the unknown Huaxia Shenzhou Laboratory.

At this point, AstraZeneca's clinical trials have been going on for four months, and they have published dozens of papers in top journals.

As for the Shenzhou Laboratory, the number of published papers has been zero since the clinical trials were conducted!
Fancheng, Shenzhou Laboratory.

"Explosive news!"

Zhu Xianqing stood at the gate of the laboratory, holding an A4 document that had just been printed out in his hand, and shouted to everyone in the laboratory hall.

"Explosive news, explosive news!"

With bright news on his face, Zhu Xianqing repeated the original words twice.

Everyone in the experiment hall looked at Zhu Xianqing suspiciously.

As one of the main persons in charge of the laboratory, Zhu Xianqing's image is generally calm and calm.

what is it today?
Jing Xiaoran was also sorting out the materials in the Shenzhou experiment, when he saw Zhu Xianqing walking in excitedly, he was full of doubts.

"Xiao Ran, something serious happened!" Zhu Xianqing walked up to Jing Xiaoran, and handed over the information in his hand.

Everyone in the experimental group of "Immune Checkpoint Inhibitors" also stopped what they were doing and gathered around.

"What's wrong? Teacher Zhu." Jing Xiaoran opened the file while talking.

"AstraZeneca's clinical trial went wrong!!!"

Zhu Xianqing said loudly.

Everyone around was shocked.

Then I heard Zhu Xianqing say: "In the affiliated hospital in Florida, among their experimental patients, there were three patients with fulminant myocarditis! All of them died after being rescued. At present, it is considered that fulminant myocarditis is caused by immunotherapy. So the AstraZeneca experiment was forced to stop."

AstraZeneca's experiment was forced to stop?

Jing Xiaoran's expression froze, he didn't expect AstraZeneca's clinical trials to stop directly.

According to the development of the previous life, there will definitely be side effects of clinical experimental drugs, and the probability of fulminant myocarditis like this is extremely low. Among thousands of experimental patients, only three cases of death occurred!

AstraZeneca has invested so much money in clinical trials of "immune checkpoint inhibitors", it is impossible to suspend the experiment directly!
Thinking of this, Jing Xiaoran immediately flipped through the materials Zhu Xianqing handed over.

The first few pages are all clinical cases with good curative effect published by AstraZeneca. There are dozens of cases in a row, all of which are cases with significant curative effect of "immune checkpoint inhibitors".

This made Jing Xiaoran a little bit dumbfounded, there is no case with such an obvious curative effect in their Shenzhou laboratory.

As one of the world's top pharmaceutical companies, AstraZeneca really has two brushes.

But flipping through the last two pages of the materials, Jing Xiaoran saw an article published by Florida General Hospital.

In this article, three deaths of patients undergoing clinical trials of "immune checkpoint inhibitors" were announced!

This is not the most critical location.

The most fundamental point for AstraZeneca to suspend clinical trials is that AstraZeneca has clearly discovered the trend of "explosive myocarditis"-abnormal myocardial enzymes, but it has concealed it.

Not only did the experimental patients not be notified, but the laboratory was not suspended.

In terms of the ethical review of the experiment, AstraZeneca obviously couldn't pass the test!
After reading these materials, Jing Xiaoran was also in a cold sweat.

Clinical trials can be said to be difficult, and if you are not careful, you may die halfway.

For AstraZeneca, it may not be long before they can continue to practice after passing the ethics review again.

But it will take a lot of time. For Shenzhou Lab, this is an excellent opportunity to catch up with the progress of clinical trials!

(End of this chapter)